Furthermore, considering that H3K79me2 enrichment of the FOXM1 promoter was detected in additional cell and tissue types, outside of the BMDCs, and pancreatic cancer and colon cancer cells addressed in this study (Figs 3A and S6), we suggested that similar mechanisms might broadly be applicable to other tissues. The gene discussed is FOXM1; the disease is pancreatic neoplasm.